New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
06:01 EDTNVAXNovavax price target raised to $9 from $7 at Piper Jaffray
Piper Jaffray raised its price target for Novavax shares to $9 and says the stock remains a top pick for 2014. Piper believes the company's RSV vaccine in development is a potential blockbuster and reiterates an Overweight rating in the stock.
News For NVAX From The Last 14 Days
Check below for free stories on NVAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NVAX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use